"Methylene Blue" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.
| Descriptor ID |
D008751
|
| MeSH Number(s) |
D02.886.369.517 D03.633.300.741.517
|
| Concept/Terms |
Methylene Blue- Methylene Blue
- Blue, Methylene
- Methylthioninium Chloride
- Swiss Blue
- Blue, Swiss
- Methylene Blue N
- Blue N, Methylene
- Methylthionine Chloride
|
Below are MeSH descriptors whose meaning is more general than "Methylene Blue".
Below are MeSH descriptors whose meaning is more specific than "Methylene Blue".
This graph shows the total number of publications written about "Methylene Blue" by people in this website by year, and whether "Methylene Blue" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Methylene Blue" by people in Profiles.
-
Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob Agents Chemother. 2013 Jan; 57(1):586-8.
-
Technical refinement of ultrasound-guided transoral resection of parapharyngeal/retropharyngeal thyroid carcinoma metastases. Head Neck. 2011 Feb; 33(2):166-70.
-
Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model. J Magn Reson Imaging. 2007 Dec; 26(6):1672-7.
-
An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancer. Urology. 2007 Oct; 70(4):822-5.
-
Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells. Am J Physiol. 1991 Dec; 261(6 Pt 2):H2024-30.